About Arbor pharma
Arbor pharma is a company based in Atlanta (United States) founded in 2006 was acquired by Azurity Pharmaceuticals in August 2021.. Arbor pharma has raised $23.14 million across 7 funding rounds from investors including KKR, Azurity Pharmaceuticals and JW Asset Management. The company has 625 employees as of December 31, 2017. Arbor pharma has completed 1 acquisition, including XenoPort. Arbor pharma offers products and services including Xifyrm and Danziten.
- Headquarter Atlanta, United States
- Employees 625 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Azurity Pharmaceuticals, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.14 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
KKR
& 4 more
-
Employee Count
625
as on Dec 31, 2017
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arbor pharma
Arbor pharma offers a comprehensive portfolio of products and services, including Xifyrm and Danziten. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Xifyrm is utilized for the management of moderate-to-severe pain in adults as an IV non-steroidal anti-inflammatory drug.
Danziten is employed in oncology treatments, with full prescribing information provided for indications and safety.
Funding Insights of Arbor pharma
Arbor pharma has successfully raised a total of $23.14M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(01 Sep 2006)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2014 | Amount | Series C - Arbor pharma | Valuation | KKR |
|
| Feb, 2013 | Amount | Debt – Conventional - Arbor pharma | Valuation |
investors |
|
| Nov, 2010 | Amount | Debt – Venture - Arbor pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arbor pharma
Arbor pharma has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include KKR, Azurity Pharmaceuticals and JW Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Investment services are offered in healthcare and cannabis sectors.
|
Founded Year | Domain | Location | |
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arbor pharma
Arbor pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include XenoPort. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biopharmaceutical products for neurological disorders and pain are provided.
|
1999 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Arbor pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arbor Pharma Comparisons
Competitors of Arbor pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Arbor pharma
When was Arbor pharma founded?
Arbor pharma was founded in 2006.
Where is Arbor pharma located?
Arbor pharma is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Is Arbor pharma a funded company?
Arbor pharma is a funded company, having raised a total of $23.14M across 7 funding rounds to date. The company's 1st funding round was a Debt – Venture of $17.3M, raised on Sep 01, 2006.
How many employees does Arbor pharma have?
As of Dec 31, 2017, the latest employee count at Arbor pharma is 625.
What does Arbor pharma do?
Arbor Pharma was founded in 2006 and is headquartered in Atlanta, United States. Operations are centered in the pharmaceutical sector, where novel dose forms of existing medications are developed to address unmet patient needs. Emphasis is placed on scaled and rapid development, strengthened commercial functions, and a workforce guided by principles of clarity, collaboration, empathy, reliability, and simplicity. High-quality medicines are targeted at underserved populations.
What products or services does Arbor pharma offer?
Arbor pharma offers Xifyrm and Danziten.
How many acquisitions has Arbor pharma made?
Arbor pharma has made 1 acquisition, including XenoPort.
Who are Arbor pharma's investors?
Arbor pharma has 5 investors. Key investors include KKR, Azurity Pharmaceuticals, JW Asset Management, Signet Healthcare Partners, and Jason Wild.